Innate Pharma Sa Asset Turnover Ratio (IPHA), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Innate Pharma Sa  (NASDAQ: IPHA)
 

Innate Pharma Sa Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the fourth quarter 2025, Innate Pharma Sa's asset turnover ratio sequentially decreased to 0.14 in the fourth quarter (Dec 31 2025), this is lower than usual.

Within sector 53 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from to 3628.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IPHA Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Asset Change -39.53 % -43.53 % -43.53 % -43.53 % -46.33 %
Y / Y Revenue Change -55.25 % - - - -67.36 %
Asset Turnover Ratio (TTM) 0.14 - - - 0.18
IPHA's Total Ranking # 3628 # # # # 3621
Seq. Asset Change 2.8 % 0 % 0 % -41.18 % -3.99 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 54
Healthcare Sector # 513
Overall Market # 3628

Asset Turnover Ratio Statistics
High Average Low
0.34 0.21 0.1
(Dec 31 2023)   (Dec 31 2021)




IPHA Company Profile • Back to IPHA Efficiency Comparisons • Compare IPHA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Grifols Sa  0.38 $ 8,426.880  Millions$ 22,077.440  Millions
Meiragtx Holdings Plc  0.38 $ 81.391  Millions$ 214.158  Millions
Viatris Inc   0.38 $ 14,299.900  Millions$ 37,999.975  Millions
Jazz Pharmaceuticals Plc  0.38 $ 4,267.586  Millions$ 11,373.662  Millions
Immunocore Holdings Plc  0.37 $ 400.016  Millions$ 1,070.041  Millions
Bionano Genomics Inc   0.37 $ 28.508  Millions$ 76.768  Millions
Bausch and Lomb Corp  0.37 $ 5,101.000  Millions$ 13,778.500  Millions
Becton Dickinson And Company  0.37 $ 20,349.000  Millions$ 55,004.750  Millions
Vanda Pharmaceuticals Inc   0.37 $ 216.105  Millions$ 586.693  Millions
Regeneron Pharmaceuticals Inc   0.37 $ 14,342.900  Millions$ 39,123.125  Millions
Inmed Pharmaceuticals Inc  0.36 $ 4.507  Millions$ 12.353  Millions
Sotera Health Company  0.36 $ 1,163.534  Millions$ 3,190.902  Millions
Schrodinger Inc   0.36 $ 255.869  Millions$ 702.774  Millions
Plus Therapeutics Inc   0.36 $ 5.213  Millions$ 14.350  Millions
Alpha Teknova Inc   0.36 $ 39.429  Millions$ 108.922  Millions
Veracyte Inc   0.36 $ 489.532  Millions$ 1,358.330  Millions
Zimmer Biomet Holdings Inc   0.36 $ 8,231.500  Millions$ 22,907.175  Millions
Fortress Biotech Inc   0.36 $ 63.262  Millions$ 176.230  Millions
Teva Pharmaceutical Industries Limited  0.35 $ 14,047.000  Millions$ 39,787.500  Millions
Elanco Animal Health Incorporated  0.35 $ 4,715.000  Millions$ 13,398.000  Millions
Invivyd Inc   0.35 $ 53.426  Millions$ 152.231  Millions
Tenon Medical Inc   0.35 $ 3.944  Millions$ 11.408  Millions
Scynexis Inc   0.35 $ 20.601  Millions$ 59.677  Millions
Biogen Inc   0.34 $ 9,890.600  Millions$ 28,752.575  Millions
Aquestive Therapeutics Inc   0.34 $ 44.545  Millions$ 129.979  Millions
Quanterix Corporation  0.34 $ 137.959  Millions$ 408.757  Millions
The Cooper Companies Inc   0.33 $ 4,151.100  Millions$ 12,394.975  Millions
Xilio Therapeutics Inc   0.33 $ 43.766  Millions$ 131.477  Millions
Regenxbio Inc   0.33 $ 170.441  Millions$ 512.548  Millions
Sanofi  0.33 $ 49,307.895  Millions$ 148,818.348  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.